WO2009044439A1 - Composition for preventing or treating liver disease - Google Patents
Composition for preventing or treating liver disease Download PDFInfo
- Publication number
- WO2009044439A1 WO2009044439A1 PCT/JP2007/069180 JP2007069180W WO2009044439A1 WO 2009044439 A1 WO2009044439 A1 WO 2009044439A1 JP 2007069180 W JP2007069180 W JP 2007069180W WO 2009044439 A1 WO2009044439 A1 WO 2009044439A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aqueous
- composition
- preventing
- salt solution
- liver disease
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000019423 liver disease Diseases 0.000 title abstract 4
- 239000012266 salt solution Substances 0.000 abstract 5
- 150000002500 ions Chemical class 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract 1
- 229910021536 Zeolite Inorganic materials 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000011114 ammonium hydroxide Nutrition 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 229910052680 mordenite Inorganic materials 0.000 abstract 1
- 231100000989 no adverse effect Toxicity 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000013535 sea water Substances 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 239000010457 zeolite Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
It is intended to provide a composition for preventing or treating liver disease including liver cancer, which has no adverse effect and is easily taken, and a food or food material having the composition blended therein. A special salt, sale de tierra, is used as an active ingredient of the composition for preventing or treating liver disease. The sale de tierra is obtained by bringing a naturally occurring ion exchanger such as zeolite (mordenite) into contact with an aqueous sodium salt solution, an aqueous potassium salt solution, an aqueous calcium salt solution, an aqueous magnesium salt solution, ammonia water, an aqueous ammonium salt solution, an aqueous inorganic acid solution, an aqueous organic acid solution, sea water, salt lake water or hot spring water to elute components contained in the naturally occurring ion exchanger through ion exchange and subsequently separating the eluate from the naturally occurring ion exchanger. Further, by blending the composition, the food or food material for preventing or treating liver disease is prepared.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009535898A JP5194022B2 (en) | 2007-10-01 | 2007-10-01 | Composition for prevention and treatment of liver disease |
| PCT/JP2007/069180 WO2009044439A1 (en) | 2007-10-01 | 2007-10-01 | Composition for preventing or treating liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2007/069180 WO2009044439A1 (en) | 2007-10-01 | 2007-10-01 | Composition for preventing or treating liver disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009044439A1 true WO2009044439A1 (en) | 2009-04-09 |
Family
ID=40525872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2007/069180 WO2009044439A1 (en) | 2007-10-01 | 2007-10-01 | Composition for preventing or treating liver disease |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5194022B2 (en) |
| WO (1) | WO2009044439A1 (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6219066A (en) * | 1985-07-17 | 1987-01-27 | Shigeo Kono | Production of specialty salt |
| JPH03293002A (en) * | 1990-04-10 | 1991-12-24 | Kaoru Kawada | Mineral liquid and its extraction method |
| JP2000007418A (en) * | 1998-06-24 | 2000-01-11 | Kazuo Sato | Production of ceramic for producing alkalie reduced water using natural zeolite, oyster shells and potassium oxide as raw material |
| JP2000024663A (en) * | 1998-07-14 | 2000-01-25 | Akira Suzuki | Electrolytically ionized water generating and purifying device |
| WO2005041657A1 (en) * | 2003-10-20 | 2005-05-12 | Framework Therapeutics, L.L.C. | Zeolite molecular sieves for the removal of toxins |
| JP2006083161A (en) * | 2004-08-17 | 2006-03-30 | Shigeo Kono | Osteogenesis promoter |
-
2007
- 2007-10-01 WO PCT/JP2007/069180 patent/WO2009044439A1/en active Application Filing
- 2007-10-01 JP JP2009535898A patent/JP5194022B2/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6219066A (en) * | 1985-07-17 | 1987-01-27 | Shigeo Kono | Production of specialty salt |
| JPH03293002A (en) * | 1990-04-10 | 1991-12-24 | Kaoru Kawada | Mineral liquid and its extraction method |
| JP2000007418A (en) * | 1998-06-24 | 2000-01-11 | Kazuo Sato | Production of ceramic for producing alkalie reduced water using natural zeolite, oyster shells and potassium oxide as raw material |
| JP2000024663A (en) * | 1998-07-14 | 2000-01-25 | Akira Suzuki | Electrolytically ionized water generating and purifying device |
| WO2005041657A1 (en) * | 2003-10-20 | 2005-05-12 | Framework Therapeutics, L.L.C. | Zeolite molecular sieves for the removal of toxins |
| JP2006083161A (en) * | 2004-08-17 | 2006-03-30 | Shigeo Kono | Osteogenesis promoter |
Non-Patent Citations (3)
| Title |
|---|
| SUZUKI M. ET AL.: "Alkali Ion-sui o Inyo saseta Koketsuatsu Shizen Hassho Rat ni okeru Enalapril no Koatsu Sayo", MEDICINE AND BIOLOGY, vol. 131, no. 6, 10 December 1995 (1995-12-10), pages 281 - 286, XP003027174 * |
| UCHIYAMA S. ET AL: "Tashurui Biryo Genso o Gan'yu suru Saldi Tierra no Rat Keiko Toyo ni yoru Kotsudoka Koka no Hatsugen", PROCEEDINGS OF THE ANNUAL MEETING OF THE PHARMACEUTICAL SOCIETY OF JAPAN, vol. 126, no. 3, 6 March 2006 (2006-03-06), pages 165, XP003027173 * |
| YAMAGUCHI M. ET AL: "Tashu Biryo Genso o Gan'yu suru Saldi Tierra no Sesshu wa Tonyobyo Narabini Kansetsuen Adjuvant Rat no Kotsugensho o Yokusei suru", BIOMED. RES. TRACE ELEMENTS, vol. 18, no. 2, 1 June 2007 (2007-06-01), pages 163, XP003027175 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2009044439A1 (en) | 2011-01-27 |
| JP5194022B2 (en) | 2013-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010068082A8 (en) | Foaming composition for high temperature and salinity | |
| AR056055A1 (en) | CRYSTALLINE AND HYDRATIC COMPLEXES OF 1-CHLORINE-4- (BETA-D-GLUCOPIRANOS-1-IL) -2- (4-ETINIL-BENCIL) -BENZENE | |
| BRPI0519316A2 (en) | herbicidal aqueous composition, and process for the preparation of a composition | |
| WO2009004512A3 (en) | Solidification matrix including a salt of a straight chain saturated mono-, di-, or tri- carboxylic acid | |
| WO2007091037A3 (en) | Metal-containing virucidal compositions and uses | |
| TW200724166A (en) | Wrinkle-improving agent | |
| WO2012165914A3 (en) | Novel diphenylmethane derivatives as sglt2 inhibitors | |
| EA200800074A1 (en) | AGRICULTURAL COMPOSITION | |
| BRPI0813712A2 (en) | SOLUBLE FORMULATION, WATER HERBICIDE COMPOSITION, METHOD TO CONTROL UNDESIRABLE VEGETATION, AND, QUINCLORAC AMMONY SALT | |
| MX2013006824A (en) | Stock cube. | |
| RU2018126051A (en) | WATER BINDER COMPOSITION | |
| AR057081A1 (en) | MEANS FOR LEATHER MANUFACTURE | |
| AR075097A1 (en) | CRYSTAL POLYMAL SALES AND FORMS OF [4- (6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-IL) -PENYL] -5-CHLORINE-THIOPHEN-2- IL-SULFONIL UREA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD TO PREPARE THEM AND USE OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATE | |
| PL2120601T3 (en) | Free-flowing gelatin composition | |
| GB0520845D0 (en) | Salt enhancing compounds and use | |
| TW200631574A (en) | Liquid seasoning | |
| WO2009044439A1 (en) | Composition for preventing or treating liver disease | |
| WO2009045655A3 (en) | Compositions containing purine nucleosides and manganese and their uses | |
| AU2003283823A1 (en) | Ergogenic multivitamin-mineral energy supplement for the prevention of muscle fatigue | |
| GT201000235A (en) | A PRODUCT TO INCREASE PHOTOSYNTHESIS | |
| WO2008078759A1 (en) | Composition comprising carnitine salt and ph-adjusting agent | |
| CN106892466A (en) | A kind of artificial seawater formula | |
| UA106580C2 (en) | The pharmaceutically acceptable salts timodepresinu and method for their production | |
| WO2007025764A3 (en) | Pharmaceutical formulations for salts of monobasic acids comprising clopidogrel | |
| CN104187048A (en) | A pig feed additive used for resisting mildew |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07828920 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009535898 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07828920 Country of ref document: EP Kind code of ref document: A1 |